GlassScriptPhysician profile
Brandy Hooper Grahn
NPI 1841673548
$2,031.47
in general payments reported to CMS, 2019-2025
26 companies · $188 in 2025
The $188 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $390 · 2020: $682 · 2021: $34.31 · 2022: $31.59 · 2023: $397 · 2024: $309 · 2025: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $894.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $893.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $620.19 | 2020-2024 | |
| Smith+Nephew, INC. | $169.82 | 2019-2024 | Collagenase Santyl, Pico, Renasys Touch |
| Tactile Systems Technology INC | $143.67 | 2020-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Integra Lifesciences Corporation | $124.95 | 2019-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Organogenesis INC. | $113.84 | 2019-2024 | Puraply |
| Amgen INC. | $105.27 | 2024-2025 | Krystexxa |
| Pfizer INC. | $95.98 | 2019 | |
| Melinta Therapeutics, LLC | $91.06 | 2019 | |
| Convatec INC. | $88.41 | 2023 | |
| Kerecis Limited | $73.26 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Abbvie INC. | $57.56 | 2022-2024 | |
| Ani Pharmaceuticals, INC. | $53.76 | 2024-2025 | Purified Cortrophin Gel |
| Medtronic, INC. | $41.59 | 2024-2025 | Intellis Adaptivestim, Inceptiv |
| Kci USA, INC. | $30.15 | 2019-2023 | Kerramax Care, Activ.A.C., Promogran Prisma |
| Solventum Corporation | $25.72 | 2025 | Activ.A.C. |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $23.50 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $22.90 | 2025 | |
| Bioventus LLC | $21.87 | 2019 | |
| Urgo Medical North America, LLC | $21.30 | 2025 | Urgoclean Ag |
| Paratek Pharmaceuticals, INC. | $20.24 | 2024 | Nuzyra |
| Lifenet Health | $18.23 | 2024 | Theragenesis Wound Matrix |
| Abbott Laboratories | $16.77 | 2019 | |
| Merck Sharp & Dohme LLC | $15.23 | 2019 | |
| Dynasplint Systems INC. | $13.25 | 2023 | Dynasplint |
| Musculoskeletal Transplant Foundation INC. | $12.71 | 2019 | |
| Normatec Industries, LP | $10.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandy Grahn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.